Navigation Links
PRO-DEX, INC. Announces Fiscal 2009 Fourth Quarter and Full-year Results
Date:9/17/2009

href="http://www.pro-dex.com/" target="_new">http://www.pro-dex.com or directly athttp://www.videonewswire.com/event.asp?id=62029. Mark Murphy, Chief Executive Officer and Jeff Ritchey, Chief Financial Officer, plan to host the call. If you would like to join the call, dial (877) 356-8625 U.S. and (706) 634-9779 International, conference I.D. 30139877. You may identify the call as the Pro-Dex Fourth Quarter Earnings Call. An online archive of the broadcast will be available within two hours of the completion of the call and will be accessible on the Company's website for 365 days. Additionally, a telephone replay will be available 2 hours after the call for 48 hours by dialing (800) 642-1687 U.S. or (706) 645-9291 for international callers, conference I.D. number 30139877.

Pro-Dex, Inc., with operations in Irvine, California, Beaverton, Oregon and Carson City, Nevada, provides a pathway to product solutions rarely envisioned by customers. A unique blend of creativity and systemic discipline enables us to develop and manufacture innovative designs that powerfully complete a customer's strategic product offering. Pro-Dex leverages extraordinary human collaboration and superior technical capability to power and control products used in medical, aerospace, military, research and industrial applications requiring high precision in harsh environments. With expertise in multi-axis motion control, fractional horsepower motors and rotary drive systems, we identify and create unexpected value for our customers.

For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the f
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Pro-Dex, Inc. Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Announces Fiscal 2009 Third Quarter Financial Results Conference Call and Webcast
3. Pro-Dex, Inc. Announces Fiscal 2008 Third Quarter Financial Results Conference Call and Webcast
4. Pro-Dex, Inc. Provides Updates on Key Developments
5. American Pacific Announces Executive Change
6. United Way of Greater Los Angeles Announces Matching Fund Launched by Two Local Philanthropists
7. Satellite Healthcare Announces the Recipients of the 2009 Norman S. Coplon Extramural Grants
8. AAF(R) Announces MEGAcel(TM) I Filter with Helior(TM) Media
9. SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test
10. Neogen Corporation Announces 1st Quarter Results Conference Call
11. MDS Announces CEO Transition Plan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...la., Dec. 4 NeoGenomic...ay that Steven C. Jones has been appointed Executi...oza has joined the company as Chief Financial Offi... all internal financial affairs of the Company. I... strategic initiatives on behalf of NeoGenomics as...
(Date:12/4/2009)...Mo., Dec. 4 Farmers Insurance Miss... Fire Marshal Randy Cole, and Brad Ballard, the CE...sponsored by Farmers called FireFacts , will ...ri Capitol December 9. ,, (Logo: http://www... "The call for fire safety comes following a tragi...
(Date:12/4/2009)...indings by UT Southwestern researchers suggest tha...s might also help slow the destruction of insulin-...h insulin-dependent (type 1) diabetes. , In typ... cells in the pancreas called beta cells, which pr...ess. , Researchers at UT Southwestern and 14 oth...
(Date:12/4/2009)...conveys true personality, study finds , ,...file on an online social network, such as Facebook...oes, reports a new study, which finds that people ...ized identities. , "I was surprised by the fin...eople are using their profiles to promote an enhan...
(Date:12/4/2009)...S, LLC, a leader in Pharmacy Inventory Management ...USA IDN Health Systems and hospitals valued at $22...mber to grow to over $30 million by the end of 200...December 4, 2009 -- PHACTS, LLC, a leader in Pharm... agreements in 2009 with USA IDN Health Systems an...
Breaking Medicine News(10 mins):Health News:NeoGenomics Announces Executive Appointments 2Health News:Missouri Safety Day at the Capitol 2Health News:FDA-approved drug may slow beta cell destruction in type 1 diabetes patients 2Health News:Online Identities Likely to Match Reality 2Health News:PHACTS Receives $22.4 Million in New Business Commitments 2
...y 'dead regions' in the brain that could be respon...ped by Karolina Kluk, a Cambridge University stude...evelopment of individualized hearing aids for chil... cannot be used with babies. The new electrophysio...
...the most common tumor to be diagnosed. It has a 99...m University Hospital of Navarra. // Sadly, the in... the recent years. It is the number one killer of ...o play a major role in the incidence of melanoma a...
...re twice as likely to develop clots in comparison ...tly, another study conducted on similar grounds //...troversial data from both sides, women who use the...mboembolic events or clots in the lungs and legs. ...
...tion for Adolescent Health has found that contrary... parents are ignorant about important sex informat...f Canadian teenagers have indulged in casual sex a...their behaviour indicated otherwise. Only 23 perce...
...ted a clinical trial of administering xenon gas to...ng so that such patients are safe from // the brai...rocedure. The team administered xenon gas to 1...om brain damage and damage to nerve cells is alway...
...ng recalled from the market as stated by the FDA d...ome cans. // So this brand would not be sold in ma... infant formula, Mead Johnson Nutritionals of EVAN...the company for the recall is public health concer...
Other Medicine News:Health News:New Test Offers Hope in Effective Hearing Aid Design for Babies 2Health News:New Technique Could Revolutionize Melanoma Diagnosis and Treatment 2Health News:Xenon Could Limit Nerve Damage After Stroke 2
(Date:12/3/2009)...Newswire-FirstCall/ -- Ted Karkus, Chairman and CE...w.quigleyco.com announced today that the Company ...to develop prescription pharmaceutical and OTC pro...erests to focus primarily on the OTC/Personal Care...d to its Cold-EEZE® and Kids-EEZE® brand...
(Date:12/3/2009)... Wound Management Tec...dly growing provider of specialty medical products...ustry Representative Association (HIRA) to serve a...representative to market the company,s core Celler...will market and sell Wound Management Technologies...
(Date:12/3/2009)...e/ -- Apnex Medical, Inc., a private medical devic...d round of private equity financing totaling $14 m...cal study and develop a second generation of its p...t obstructive sleep apnea (OSA). ,, Participant...Enterprise Associates (NEA), Polaris Venture Partn...
Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 1National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 2National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 3National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 4PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 1PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 2PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 3PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 4PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 5Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 1Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 2Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 3Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 4
... Extension of Phase II Study Demonstrates Signific...ne, LEXINGTON, Mass., June 12, 2007 /PRNewswire-Fi...nounced that results from the,Company,s Phase II E...ntal stuttering will be presented today at the 47t...on Unit (NCDEU), sponsored,by National Institute f...
... activity reported against CTCL, PTCL and Ovarian ...ire-FirstCall/ -- CuraGen,Corporation , a clinical...gy, presented today an update on the clinical deve...ase (HDAC) inhibitor, and,reported updated results...t cutaneous T-cell lymphoma (CTCL), peripheral T-c...
Other Medicine Technology:Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9CuraGen Presents Update on Clinical Development Program for,Belinostat 2CuraGen Presents Update on Clinical Development Program for,Belinostat 3CuraGen Presents Update on Clinical Development Program for,Belinostat 4CuraGen Presents Update on Clinical Development Program for,Belinostat 5CuraGen Presents Update on Clinical Development Program for,Belinostat 6CuraGen Presents Update on Clinical Development Program for,Belinostat 7CuraGen Presents Update on Clinical Development Program for,Belinostat 8
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: